Exploring how stigma affects methamphetamine use and HIV prevention among Latino men who have sex with men.
Addressing intersectional stigma through coping, resistance, and resilience to improve methamphetamine use and factors influencing PrEP uptake among Latino MSM: a step towards ending HIV by 2030
This study looks at how different types of stigma affect methamphetamine use and the willingness to take PrEP among Latino men who have sex with men, aiming to find ways to support their health better.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Arizona State University-Tempe Campus NIH-funded |
| Lab location | 1 site (Tempe, United States) |
| Project ID | NIH-10906228 on NIH RePORTER |
What this research studies
This research investigates the impact of intersectional stigma on methamphetamine use and the uptake of PrEP (pre-exposure prophylaxis) among Latino men who have sex with men (LMSM). It aims to understand how various sources of stigma, such as those from family and friends, influence health behaviors and outcomes. By using social network analysis and advanced statistical modeling, the study will explore the relationships between stigma, coping mechanisms, and resilience in this population. The findings could inform targeted interventions to improve health outcomes for LMSM facing stigma.
Who could benefit from this research
Good fit: Ideal candidates for this research are Latino men who have sex with men and are affected by stigma related to their sexual orientation or substance use.
Not a fit: Patients who do not identify as Latino or who do not engage in behaviors related to methamphetamine use or PrEP uptake may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for reducing stigma and increasing PrEP uptake, ultimately helping to end the HIV epidemic among Latino MSM.
How similar studies have performed: Previous research has shown that addressing stigma can significantly improve health outcomes in marginalized populations, suggesting that this approach may be effective.
Where this research is happening
Tempe, United States
- Arizona State University-Tempe Campus — Tempe, United States (Active)
Researchers
- Principal investigator: Algarin, Angel B — Arizona State University-Tempe Campus
- Study coordinator: Algarin, Angel B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.